On September 1, 2023 at 15:49:51 ET an unusually large $1,179.56K block of Call contracts in Affirm Holdings Inc – (AFRM) was bought, with Read More
The average one-year price target for Dish TV India (LSE:DTVL) has been revised to 0.13 / share. This is an decrease Read More
The average one-year price target for Molecular Partners (OTC:MLLCF) has been revised to 8.84 / share. This is an decrease of 30.37% Read More
The average one-year price target for Akumin (TSE:AKU) has been revised to 1.67 / share. This is an decrease of 47.84% from Read More
The average one-year price target for Chesnara (LSE:CSN) has been revised to 365.92 / share. This is an decrease of 5.18% from Read More
Russia launched a 3 1/2-hour drone attack on the southern parts of the Odesa region early on Sunday, hitting a Danube Read More
Calling himself one of the “humble heirs” of ancient schools of wisdom and quoting the Buddha, Pope Francis on Sunday Read More
Being a member of Congress comes with a slew of financial perks. In addition to a rewarding salary, U.S. Read More
Social Security: SSA Expediates Disability Application Process
The Social Security Administration’s (SSA) Compassionate Allowances (CAL) program is designed to accelerate the application process of disability claims Read More
DoubleLine ETF Trust – DoubleLine Commercial Real Estate ETF said on August 31, 2023 that its board of directors declared a regular monthly Read More
When it comes to buying groceries, timing can affect your wallet. This is because shopping on the wrong day not Read More
A Ukrainian court on Saturday ordered business magnate Ihor Kolomoisky, accused of fraud and money laundering, taken into custody for Read More
The average one-year price target for Sun TV Network (NSE:SUNTV) has been revised to 614.11 / share. This is an increase Read More
Trust For Professional Managers – ActivePassive Intermediate
Trust For Professional Managers – ActivePassive Intermediate Municipal Bond ETF said on August 31, 2023 that its board of directors declared a regular Read More
The average one-year price target for Eris Lifesciences (NSE:ERIS) has been revised to 917.69 / share. This is an increase of 13.89% Read More








